Literature DB >> 18485376

Prognostic stratification of localized renal cell carcinoma by tumor size.

Jens Bedke1, Maria Pritsch, Stephan Buse, Hildegard Jakobi, Karl-Heinz Elsaesser, Sascha Pahernik, Axel Haferkamp, Markus Hohenfellner.   

Abstract

PURPOSE: Recent retrospective studies have challenged the current TNM classification of 7.0 cm to distinguish between T1 and T2 tumors. We reevaluated the optimal tumor size cutoff point that independently differentiates patient prognosis beyond the other accepted prognostic features.
MATERIALS AND METHODS: From 1990 to October 2006, 398 patients who underwent radical nephrectomy for localized renal cell carcinoma (T1-T2, N0, M0) were followed prospectively. Median followup was 5.3 years and 37 patients died of tumor related causes. The optimal tumor cutoff point was calculated and multivariate Cox proportional hazards models were used to adjust for the effects of Fuhrman grade, tumor type, sex, age and Karnofsky performance status on cancer specific survival. Sensitivity analysis included all 66 patients with elective nephron sparing surgery.
RESULTS: Univariate analysis supported 7 cm as the optimal cutoff point for prognostic stratification (p = 0.002). The 4 cm cutoff point that is used to distinguish between stage T1a and T1b could not be confirmed with analogous statistical significance (p = 0.20). On multivariate analysis tumor size dichotomized at 7 cm was an independent prognostic factor (HR 2.89, 95% CI 1.46-5.73, p = 0.002), as was Fuhrman grade 3 (HR 3.68, 95% CI 1.37-9.83, p = 0.010) and age older than 60 years (HR 3.64, 95% CI 1.63-8.14, p = 0.002). The inclusion of patients with elective nephron sparing surgery confirmed these results.
CONCLUSIONS: Univariate and multivariate analyses of our patient cohort undergoing radical nephrectomy for localized renal cell carcinoma showed no cutoff point other than 7 cm to be more suitable for distinguishing between T1 and T2 tumors, supporting the current TNM classification. In T1 tumors the analysis did not allow a clear dichotomization of tumor size in this group.

Entities:  

Mesh:

Year:  2008        PMID: 18485376     DOI: 10.1016/j.juro.2008.03.026

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  [Current guideline-oriented follow-up of small renal masses : Applied risk scores and future outlook].

Authors:  V Stühler; S Kruck; T Todenhöfer; A Stenzl; J Bedke
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

2.  [Renal cell carcinoma: recent developments in diagnostics and therapy].

Authors:  J Bedke; A Stenzl
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 3.  Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis.

Authors:  Phillip M Pierorazio; Michael H Johnson; Hiten D Patel; Stephen M Sozio; Ritu Sharma; Emmanuel Iyoha; Eric B Bass; Mohamad E Allaf
Journal:  J Urol       Date:  2016-05-06       Impact factor: 7.450

4.  CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma.

Authors:  Walter Henriques da Costa; Rafael Malagoli Rocha; Isabela Werneck da Cunha; Francisco Paula da Fonseca; Gustavo Cardoso Guimaraes; Stenio de Cassio Zequi
Journal:  World J Urol       Date:  2011-10-04       Impact factor: 4.226

5.  Analysis of long-term survival in patients with localized renal cell carcinoma: laparoscopic versus open radical nephrectomy.

Authors:  Jun-Hang Luo; Fang-Jian Zhou; Dan Xie; Zhi-Ling Zhang; Bing Liao; Hong-Wei Zhao; Yu-Ping Dai; Ling-Wu Chen; Wei Chen
Journal:  World J Urol       Date:  2009-11-15       Impact factor: 4.226

6.  The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma.

Authors:  Stênio de Cássio Zequi; José Humberto G T Fregnani; Ricardo L Favaretto; Walter H Costa; Rodrigo S Madeira Campos; Francisco P Fonseca; Gustavo C Guimaraes; Fernando A Soares; Isabela W da Cunha; Ademar Lopes
Journal:  World J Urol       Date:  2012-05-06       Impact factor: 4.226

7.  Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.

Authors:  Zhi-Ling Zhang; Wei Chen; Yong-Hong Li; Zhuo-Wei Liu; Jun-Hang Luo; Weber Lau; Min-Han Tan; Fang-Jian Zhou
Journal:  Chin J Cancer       Date:  2011-11

8.  Skewed T-helper (Th)1/2- and Th17/T regulatory‑cell balances in patients with renal cell carcinoma.

Authors:  Long Li; Cheng Yang; Zitong Zhao; Bin Xu; Minghuan Zheng; Chao Zhang; Zhihui Min; Jianming Guo; Ruiming Rong
Journal:  Mol Med Rep       Date:  2014-10-27       Impact factor: 2.952

9.  Impact of age on the cancer-specific survival of patients with localized renal cell carcinoma: martingale residual and competing risks analysis.

Authors:  Muyan Cai; Jinhuan Wei; Zhiling Zhang; Hongwei Zhao; Yunqiao Qiu; Yong Fang; Zhenli Gao; Jiazheng Cao; Wei Chen; Fangjian Zhou; Dan Xie; Junhang Luo
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.